Linden Capital Partners
Private equity firm focused exclusively on healthcare. Provides buyout and structured capital investments combined with a proprietary Value Creation Program (VCP), active board-level involvement, operating partner engagements, human capital services, and finance/portfolio analytics to support growth, operational improvement, and exits for healthcare companies.
Industries
N/A
Nr. of Employees
small (1-50)
Linden Capital Partners
Services
Lead investor buyouts and other control-oriented investments in healthcare companies, with hands-on post-acquisition support.
Structured capital fund investing and tailored capital solutions distinct from traditional buyouts.
Tailored operational roadmaps and implementation support, leveraging operating partners and in-house teams to drive measurable improvements.
Executive search, leadership assessment, and talent management provided by an in-house Human Capital team.
Fund administration, portfolio performance analytics, and investor relations support for investors and portfolio companies.
Placement of senior operating partners on boards and access to an expansive advisory network spanning clinical, regulatory, reimbursement, and scientific domains.
Lead investor buyouts and other control-oriented investments in healthcare companies, with hands-on post-acquisition support.
Structured capital fund investing and tailored capital solutions distinct from traditional buyouts.
Tailored operational roadmaps and implementation support, leveraging operating partners and in-house teams to drive measurable improvements.
Executive search, leadership assessment, and talent management provided by an in-house Human Capital team.
Fund administration, portfolio performance analytics, and investor relations support for investors and portfolio companies.
Placement of senior operating partners on boards and access to an expansive advisory network spanning clinical, regulatory, reimbursement, and scientific domains.
Expertise Areas
- Private equity investing in healthcare
- Value creation and operational improvement for portfolio companies
- Sector-focused diligence (providers, devices, diagnostics, pharma services, HCIT, contract manufacturing)
- Board governance and active ownership
Key Technologies
- Portfolio analytics and financial modeling
- Fund administration systems
- Health care IT (HCIT)
- Clinical research platforms (infrastructure and partnerships)
News & Updates
Announcement of Gadi Lachman joining the firm as an Operating Partner.
Announcement of Bruce Broussard joining the firm as an Operating Partner.
Announcement of Dr. Auro Nair joining the firm as an Operating Partner.
Announcement that the firm completed the Fund VI raise at $5.4 billion.
Announcement of final close of Structured Capital Fund II at $400 million.
Completed an oversubscribed fundraising for Fund VI totaling $5.4 billion.
Announcement of Gadi Lachman joining the firm as an Operating Partner.
Announcement of Bruce Broussard joining the firm as an Operating Partner.
Announcement of Dr. Auro Nair joining the firm as an Operating Partner.
Announcement that the firm completed the Fund VI raise at $5.4 billion.
Announcement of final close of Structured Capital Fund II at $400 million.
Completed an oversubscribed fundraising for Fund VI totaling $5.4 billion.